Evidence map›Paper›PMID 41593558›Full record

Trial reportBMC musculoskeletal disorders2026

Comparative efficacy of corticosteroid injection, extracorporeal shock wave therapy, and radiofrequency ablation for chronic plantar fasciitis: a prospective randomized controlled trial.

Mehmed Nuri Tütüncü, Merve Sekizkardeş, Erdem Şahin, Bedri Karaismailoğlu

Registry-linked trialAbstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06737445 (Comparative Efficacy of Corticosteroid Injection, Extracorporeal Shock Wave Therapy, and Radiofrequency Ablation for Chronic Plantar Fasciitis), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06737445 nacompletednot on this map

Comparative Efficacy of Corticosteroid Injection, Extracorporeal Shock Wave Therapy, and Radiofrequency Ablation for Chronic Plantar Fasciitis: A Prospective Randomized Controlled Trial

TypeinterventionalSponsorKars Harakani State HospitalRan2021 to 2023Enrolled49ConditionsChronic Plantar FasciitisArmsRadiofrequency ablation alone, Cortisone Injection, Extracorporeal shock wave therapy
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mehmed Nuri TütüncüDepartment of Orthopaedics and Traumatology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Egitim Mah,Fahrettin Kerim Gokay Caddesi 161/14, Kadıköy, İstanbul, Turkey. mnuritutuncu@hotmail.com.ORCID http://orcid.org/0000-0002-0861-1477
Merve SekizkardeşDepartment of Physical Medicine and Rehabilitation, Division of Pain Medicine, Marmara University Pendik Training and Research Hospital, İstanbul, Turkey.ORCID http://orcid.org/0000-0001-7395-4591
Erdem ŞahinDepartment of Orthopaedics and Traumatology, Istanbul University - Cerrahpasa, İstanbul, Turkey.ORCID http://orcid.org/0000-0001-8333-0803
Bedri KaraismailoğluDepartment of Orthopaedics and Traumatology, Istanbul University - Cerrahpasa, İstanbul, Turkey.ORCID http://orcid.org/0000-0002-4565-6383

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic plantar fasciitis is a common cause of persistent heel pain, often resistant to conservative treatments. This prospective, randomized controlled trial (ClinicalTrials.gov: NCT06737445) aimed to compare the effectiveness of corticosteroid injection (CSI), extracorporeal shock wave therapy (ESWT), and radiofrequency thermal lesioning (RTL) in managing chronic plantar fasciitis.

methodsPatients with chronic plantar fasciitis, unresponsive to 6 months of conservative treatment, were included. They were divided into three groups: CSI, ESWT, and RTL. Corticosteroid injections were given under ultrasound guidance, ESWT was applied weekly for three weeks, and RTL was a single-session procedure. The primary outcome was change in Visual Analog Scale (VAS) for pain. Secondary outcomes included the Foot Function Index (FFI) and Roles and Maudsley score, assessed at baseline, 1, 6, and 12 months post-treatment.

resultsThe CSI group included 20 feet from 18 patients, the ESWT group had 19 feet from 15 patients, and the RTL group included 23 feet from 16 patients. At 12 months, the RTL group showed significantly better outcomes in the Roles and Maudsley Score compared to ESWT and CSI, with no significant differences at 1 and 6 months. In FFI, the RTL group had significantly better scores than ESWT at 6 and 12 months. For VAS scores, the CSI group had better outcomes than ESWT at 1 month, but by 6 and 12 months, RTL demonstrated superior pain relief compared to both CSI and ESWT.

conclusionRTL proved to be the most effective treatment for chronic plantar fasciitis, showing superior results, particularly at 12 months, in the Roles and Maudsley Score, Foot Function Index, and VAS scores compared to ESWT and CSI. LEVEL OF EVIDENCE: Level 1, prospective randomized controlled study.

Indexed as

Adrenal Cortex HormonesExtracorporeal Shockwave TherapyFasciitis, PlantarRadiofrequency AblationAdultChronic DiseaseFemaleHumansMaleMiddle AgedPain MeasurementProspective StudiesTreatment OutcomeAdrenal Cortex HormonesChronic plantar fasciitisCorticosteroid injectionExtracorporeal shock wave therapy (ESWT)Radiofrequency thermal lesioning (RTL)

Identifiers

PMID41593558
PMCPMC12918559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.